Literature DB >> 9761238

Plasma concentration, kinetic constants, and gene polymorphism of angiotensin I-converting enzyme in centenarians.

L Faure-Delanef1, B Baudin, B Bénéteau-Burnat, J C Beaudoin, J Giboudeau, D Cohen.   

Abstract

We have determined serum activity and kinetic constants of angiotensin I-converting enzyme (ACE), parallel to an insertion/deletion (I/D) polymorphism in its gene, in French centenarians and controls 20-70 years of age because this enzyme could have an impact on cardiovascular risk, and thus on longevity. Both the ACE D allele and ACE D/D genotype were more frequent in centenarians in comparison with controls, without sex-related differences nor significant correlation with a cardiovascular pathology. In centenarians, I/D polymorphism was correlated with circulating ACE activity (D/D genotype, 89.0 +/- 36.8 U/L; I/D genotype, 63.5 +/- 26.0 U/L; and I/I genotype, 55.1 +/- 39.4 U/L). The Michaelis constants for two substrates were identical whatever the genotype and were not different between centenarians and controls, i.e., 0.30 +/- 0.03 mmol/L for furylacryloyl-phenylalanyl-glycyl-glycine and 1.35 +/- 0.05 mmol/L for hippuryl-histidyl-leucine; for the latter, the optimal pH and activating concentration of chloride did not depend on I/D polymorphism. The maximal velocities with both substrates reflected the distribution of serum ACE activity as a function of the genotypes, in centenarians and in controls. In conclusion, plasma ACE activity is subject to a similar genotypic influence in centenarians as in adults 20-70 years of age; however, ACE itself appears to be functionally similar for each genotype. Furthermore, the D allele as well as the higher serum ACE activities associated with the D/D genotype cannot discriminate individuals at high risk for cardiovascular diseases, major causes of mortality before the age of 100 years.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9761238

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  Angiotensin-converting enzyme insertion/deletion polymorphism genotyping error: the cause and a possible solution to the problem.

Authors:  Andrea Saracevic; Ana-Maria Simundic; Ivana Celap; Valentina Luzanic
Journal:  Mol Biol Rep       Date:  2013-05-09       Impact factor: 2.316

2.  Hypertension and longevity: role of genetic polymorphisms in renin-angiotensin-aldosterone system and endothelial nitric oxide synthase.

Authors:  Alda Pereira da Silva; Andreia Matos; Laura Aguiar; Nuno Ramos-Marques; Ricardo Ribeiro; Ângela Gil; João Gorjão-Clara; Manuel Bicho
Journal:  Mol Cell Biochem       Date:  2018-11-20       Impact factor: 3.396

Review 3.  Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications.

Authors:  Tianhua Niu; Xiu Chen; Xiping Xu
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents?

Authors:  Pei Wang; Matthew N Fedoruk; Jim L Rupert
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

Review 5.  We are ageing.

Authors:  Genovefa D Kolovou; Vana Kolovou; Sophie Mavrogeni
Journal:  Biomed Res Int       Date:  2014-06-22       Impact factor: 3.411

Review 6.  Puzzling role of genetic risk factors in human longevity: "risk alleles" as pro-longevity variants.

Authors:  Svetlana Ukraintseva; Anatoliy Yashin; Konstantin Arbeev; Alexander Kulminski; Igor Akushevich; Deqing Wu; Gaurang Joshi; Kenneth C Land; Eric Stallard
Journal:  Biogerontology       Date:  2015-08-26       Impact factor: 4.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.